RATIONALE: Although interferon (IFN)-gamma release assays are approved for the diagnosis of latent tuberculosis infection (LTBI), limited data exist regarding their performance in HIV infection. OBJECTIVES: To compare tuberculin skin test (TST) results to the commercial IFN-gamma release assay QuantiFERON-TB Gold In-Tube (QFT) for the diagnosis of LTBI in HIV-infected adults. METHODS: A total of 294 HIV-infected subjects sampled from two San Francisco cohorts underwent TST, using 5 TU of purified protein derivative, and QFT, measuring IFN-gamma response to Mycobacterium tuberculosis-specific RD-1 antigens. MAIN RESULTS: Of 294 participants, 205 (70%) returned for an evaluable TST. Concordance between QFT and TST was 89.3% (kappa=0.37, p=0.007). However, in subjects with positive test results by either TST or QFT, only 28% (8/29) had positive test results by both modalities. TST-positive/QFT-negative discordant results were found in 5.1% of subjects and TST-negative/QFT-positive discordance in 5.6%. Indeterminate QFT results occurred in 5.1%, all due to a failure to respond to the phytohemagglutinin-positive control. Subjects with a CD4(+) count of less than 100 cells/mm(3) had a relative risk of an indeterminate result of 4.24 (95% confidence interval, 1.55-11.61; p=0.003) compared with those with a CD4(+) count of 100 or more. CONCLUSIONS: Overall concordance between QFT and TST in HIV infection was high, but agreement among subjects with positive tests by either modality was low.
RATIONALE: Although interferon (IFN)-gamma release assays are approved for the diagnosis of latent tuberculosis infection (LTBI), limited data exist regarding their performance in HIV infection. OBJECTIVES: To compare tuberculin skin test (TST) results to the commercial IFN-gamma release assay QuantiFERON-TB Gold In-Tube (QFT) for the diagnosis of LTBI in HIV-infected adults. METHODS: A total of 294 HIV-infected subjects sampled from two San Francisco cohorts underwent TST, using 5 TU of purified protein derivative, and QFT, measuring IFN-gamma response to Mycobacterium tuberculosis-specific RD-1 antigens. MAIN RESULTS: Of 294 participants, 205 (70%) returned for an evaluable TST. Concordance between QFT and TST was 89.3% (kappa=0.37, p=0.007). However, in subjects with positive test results by either TST or QFT, only 28% (8/29) had positive test results by both modalities. TST-positive/QFT-negative discordant results were found in 5.1% of subjects and TST-negative/QFT-positive discordance in 5.6%. Indeterminate QFT results occurred in 5.1%, all due to a failure to respond to the phytohemagglutinin-positive control. Subjects with a CD4(+) count of less than 100 cells/mm(3) had a relative risk of an indeterminate result of 4.24 (95% confidence interval, 1.55-11.61; p=0.003) compared with those with a CD4(+) count of 100 or more. CONCLUSIONS: Overall concordance between QFT and TST in HIV infection was high, but agreement among subjects with positive tests by either modality was low.
Authors: Inger Brock; Karin Weldingh; Troels Lillebaek; Frank Follmann; Peter Andersen Journal: Am J Respir Crit Care Med Date: 2004-04-15 Impact factor: 21.405
Authors: J Y Lee; H J Choi; I-N Park; S-B Hong; Y-M Oh; C-M Lim; S D Lee; Y Koh; W S Kim; D S Kim; W D Kim; T S Shim Journal: Eur Respir J Date: 2006-04-12 Impact factor: 16.671
Authors: Edward C Jones-López; Alphonse Okwera; Harriet Mayanja-Kizza; Jerrold J Ellner; Roy D Mugerwa; Christopher C Whalen Journal: Am J Trop Med Hyg Date: 2006-01 Impact factor: 2.345
Authors: Madhukar Pai; Kaustubh Gokhale; Rajnish Joshi; Sandeep Dogra; Shriprakash Kalantri; Deepak K Mendiratta; Pratibha Narang; Charles L Daley; Reuben M Granich; Gerald H Mazurek; Arthur L Reingold; Lee W Riley; John M Colford Journal: JAMA Date: 2005-06-08 Impact factor: 56.272
Authors: L E Duncan; A M Elliott; R J Hayes; S K Hira; G Tembo; G T Mumba; S H Ebrahim; M Quigley; J O Pobee; K P McAdam Journal: Trans R Soc Trop Med Hyg Date: 1995 Jan-Feb Impact factor: 2.184
Authors: S A Clark; S L Martin; A Pozniak; A Steel; B Ward; J Dunning; D C Henderson; M Nelson; B Gazzard; P Kelleher Journal: Clin Exp Immunol Date: 2007-08-02 Impact factor: 4.330
Authors: M Bocchino; A Matarese; B Bellofiore; P Giacomelli; G Santoro; N Balato; F Castiglione; R Scarpa; F Perna; G Signoriello; D Galati; A Ponticiello; A Sanduzzi Journal: Eur J Clin Microbiol Infect Dis Date: 2008-05-10 Impact factor: 3.267
Authors: Peter J Dodd; Kerry A Millington; Azra C Ghani; Junior Mutsvangwa; Anthony E Butterworth; Ajit Lalvani; Elizabeth L Corbett Journal: Am J Epidemiol Date: 2010-04-09 Impact factor: 4.897
Authors: Martine G Aabye; Pernille Ravn; George PrayGod; Kidola Jeremiah; Apolinary Mugomela; Maria Jepsen; Daniel Faurholt; Nyagosya Range; Henrik Friis; John Changalucha; Aase B Andersen Journal: PLoS One Date: 2009-01-19 Impact factor: 3.240